Stanford broadens amplification licence:
This article was originally published in Clinica
Stanford University (US) has broadened the licence to its patent rights covering transcription-based amplification technology. An exclusive licence with Gen-Probe has been converted to a co-exclusive agreement, enabling both Gen-Probe and Organon Teknika to practise under the relevant patents. The companies will also be able to license versions of the technology, which is being used to develop new-generation tests for the diagnosis of infectious diseases, cancer and genetic disorders.
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.